HOME > BUSINESS
BUSINESS
- Fujifilm to Introduce Automatic Aseptic Filling System in US Bio CDMO Hub
January 16, 2019
- Mitsubishi Tanabe Stepping Up Rupafin Promotion in November: Anterio
January 15, 2019
- Japan Pharma Market Sags 2% in April-December as Pricing Overhaul Weighs: Encise
January 15, 2019
- Avastin Top-Seller Medicine in Japan in December: Encise Snapshot
January 11, 2019
- Wakamoto Kicks Off Japan PIII for Glaucoma Drug
January 11, 2019
- Latuda Succeeds in PIII Schizophrenia Study, Japan NDA Submission Planned by September
January 11, 2019
- Fujifilm’s Next-Generation Technology Doubles Antibody Productivity, Reduces Production Time by 30%
January 11, 2019
- NanoCarrier Submits CTA in EU for PII Study of NC-6004-Keytruda Combo for Head and Neck Cancer
January 11, 2019
- Daiichi Sankyo, Tokyo Institute of Technology Launch Open Innovation Research for Type 1 Diabetes Treatment Using iPS Cells
January 11, 2019
- Opdivo Extends OS in Second-Line Esophageal Cancer
January 10, 2019
- Chugai Completes Transfer of 13 Off-Patent Brands to Taiyo
January 10, 2019
- Kowa, Nissan Chemical Win US Patent Case over Livalo Crystal Form
January 10, 2019
- Meiji to Set Up JV with Canadian Firm to Develop Novel β-lactamase Inhibitor
January 9, 2019
- Eisai Recalls Azeptin after It Fails Dissolution Tests
January 9, 2019
- Investigator-Initiated US PII Study to Start for Telomelysin/Keytruda Combo: Oncolys
January 9, 2019
- Kyorin Introduces Voluntarily Recall of Desalex
January 9, 2019
- Fycompa Designated for Priority Review in China
January 9, 2019
- Takeda Completes £46 Billion Shire Acquisition
January 8, 2019
- Kyowa Kirin Files Burosumab in Japan
January 8, 2019
- Takeda Revving Up Collaboration Efforts on I/O Front
January 8, 2019
ページ
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
